10-K Filing

ABBVIE INC. CIK: 1551152 FY 2020

Filing Information

Form Type	10-K
Accession Number	`0001551152-21-000008`
Period End Date	20201231
Filing Date	20210219
Fiscal Year	2020
Fiscal Period	FY
XBRL Instance	abbv-20201231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 69 Income Statement 64 Cash Flow Statement 132 Stockholders Equity 26 Comprehensive Income 45

Balance Sheet 69 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, authorized (in shares)	`CommonStockSharesAuthorized`	4.00B	shares	Point-in-time
Common stock, authorized (in shares)	`CommonStockSharesAuthorized`	4.00B	shares	Point-in-time
Common stock, issued (in shares)	`CommonStockSharesIssued`	1.79B	shares	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$8.45B	USD	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$39.92B	USD	Point-in-time
Common stock, issued (in shares)	`CommonStockSharesIssued`	1.78B	shares	Point-in-time
Short-term investments	`ShortTermInvestments`	-	USD	Point-in-time
Common stock held in treasury, at cost (in shares)	`TreasuryStockShares`	302.67M	shares	Point-in-time
Short-term investments	`ShortTermInvestments`	$30.00M	USD	Point-in-time
Common stock held in treasury, at cost (in shares)	`TreasuryStockShares`	27.01M	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$5.43B	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$8.82B	USD	Point-in-time
Inventories	`InventoryNet`	$1.81B	USD	Point-in-time
Inventories	`InventoryNet`	$3.31B	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssets`	$3.56B	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssets`	$2.35B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$24.17B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$49.52B	USD	Point-in-time
Investments	`LongTermInvestments`	$293.00M	USD	Point-in-time
Investments	`LongTermInvestments`	$93.00M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.96B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.25B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$18.65B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$82.88B	USD	Point-in-time
Goodwill	`Goodwill`	$33.12B	USD	Point-in-time
Goodwill	`Goodwill`	$15.66B	USD	Point-in-time
Goodwill	`Goodwill`	$15.60B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.85B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$2.29B	USD	Point-in-time
Total assets	`Assets`	$150.56B	USD	Point-in-time
Total assets	`Assets`	$89.11B	USD	Point-in-time
Short-term borrowings	`ShortTermBorrowings`	-	USD	Point-in-time
Short-term borrowings	`ShortTermBorrowings`	$34.00M	USD	Point-in-time
Current portion of long-term debt and finance lease obligations	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$3.75B	USD	Point-in-time
Current portion of long-term debt and finance lease obligations	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$8.47B	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$11.83B	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$20.16B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$28.66B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$15.59B	USD	Point-in-time
Long-term debt and finance lease obligations	`LongTermDebtAndCapitalLeaseObligations`	$77.55B	USD	Point-in-time
Long-term debt and finance lease obligations	`LongTermDebtAndCapitalLeaseObligations`	$62.98B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$1.13B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$3.65B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$27.61B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$17.60B	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.01 par value, 4,000,000,000 shares authorized, 1,792,140,764 shares issued as of December 31, 2020 and 1,781,582,608 as of December 31, 2019	`CommonStockValueOutstanding`	$18.00M	USD	Point-in-time
Common stock, $0.01 par value, 4,000,000,000 shares authorized, 1,792,140,764 shares issued as of December 31, 2020 and 1,781,582,608 as of December 31, 2019	`CommonStockValueOutstanding`	$18.00M	USD	Point-in-time
Common stock held in treasury, at cost, 27,007,945 shares as of December 31, 2020 and 302,671,146 as of December 31, 2019	`TreasuryStockValue`	$2.26B	USD	Point-in-time
Common stock held in treasury, at cost, 27,007,945 shares as of December 31, 2020 and 302,671,146 as of December 31, 2019	`TreasuryStockValue`	$24.50B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$17.38B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$15.19B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.05B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$4.72B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-3.12B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-3.60B	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-8.17B	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$13.08B	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$21.00M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	-	USD	Point-in-time
Total equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.10B	USD	Point-in-time
Total equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-8.17B	USD	Point-in-time
Total equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.10B	USD	Point-in-time
Total equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-8.45B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$89.11B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$150.56B	USD	Point-in-time

Income Statement 64 line items

Line Item	Tag	Value	Unit	Period
Net revenues	`Revenues`	$33.27B	USD	Annual
Net revenues	`Revenues`	$45.80B	USD	Annual
Net revenues	`Revenues`	$32.75B	USD	Annual
Net revenues	`Revenues`	$13.86B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$7.72B	USD	Annual
Cost of products sold	`CostOfGoodsAndServicesSold`	$7.44B	USD	Annual
Cost of products sold	`CostOfGoodsAndServicesSold`	$15.39B	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$6.94B	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$11.30B	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$7.40B	USD	Annual
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$6.41B	USD	Annual
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$6.56B	USD	Annual
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$10.33B	USD	Annual
Acquired in-process research and development	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$1.20B	USD	Annual
Acquired in-process research and development	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$424.00M	USD	Annual
Acquired in-process research and development	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$385.00M	USD	Annual
Other operating (income) expense	`OtherOperatingIncomeExpenseNet`	$890.00M	USD	Annual
Other operating (income) expense	`OtherOperatingIncomeExpenseNet`	-	USD	Annual
Other operating (income) expense	`OtherOperatingIncomeExpenseNet`	$-500.00M	USD	Annual
Total operating costs and expenses	`CostsAndExpenses`	$20.28B	USD	Annual
Total operating costs and expenses	`CostsAndExpenses`	$34.44B	USD	Annual
Total operating costs and expenses	`CostsAndExpenses`	$26.37B	USD	Annual
Operating earnings	`OperatingIncomeLoss`	$12.98B	USD	Annual
Operating earnings	`OperatingIncomeLoss`	$6.38B	USD	Annual
Operating earnings	`OperatingIncomeLoss`	$11.36B	USD	Annual
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-2.28B	USD	Annual
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-1.51B	USD	Annual
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-1.14B	USD	Annual
Net foreign exchange loss	`ForeignCurrencyTransactionGainLossBeforeTax`	$-42.00M	USD	Annual
Net foreign exchange loss	`ForeignCurrencyTransactionGainLossBeforeTax`	$-24.00M	USD	Annual
Net foreign exchange loss	`ForeignCurrencyTransactionGainLossBeforeTax`	$-71.00M	USD	Annual
Other expense, net	`OtherNonoperatingIncomeExpense`	$-3.01B	USD	Annual
Other expense, net	`OtherNonoperatingIncomeExpense`	$-5.61B	USD	Annual
Other expense, net	`OtherNonoperatingIncomeExpense`	$-18.00M	USD	Annual
Earnings before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$8.43B	USD	Annual
Earnings before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$3.40B	USD	Annual
Earnings before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$5.20B	USD	Annual
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$-490.00M	USD	Annual
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$-1.22B	USD	Annual
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$544.00M	USD	Annual
Net earnings	`ProfitLoss`	$5.69B	USD	Annual
Net earnings	`ProfitLoss`	$7.88B	USD	Annual
Net earnings	`ProfitLoss`	$4.62B	USD	Annual
Net earnings attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$6.00M	USD	Annual
Net earnings attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	Annual
Net earnings attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	Annual
Net earnings attributable to AbbVie Inc.	`NetIncomeLoss`	$5.69B	USD	Annual
Net earnings attributable to AbbVie Inc.	`NetIncomeLoss`	$4.62B	USD	Annual
Net earnings attributable to AbbVie Inc.	`NetIncomeLoss`	$7.88B	USD	Annual
Net earnings attributable to AbbVie Inc.	`NetIncomeLoss`	$36.00M	USD	1 Quarter
Basic earnings per share (in dollars per share)	`EarningsPerShareBasic`	$0.01	USD	1 Quarter
Basic earnings per share (in dollars per share)	`EarningsPerShareBasic`	$3.67	USD	Annual
Basic earnings per share (in dollars per share)	`EarningsPerShareBasic`	$2.73	USD	Annual
Basic earnings per share (in dollars per share)	`EarningsPerShareBasic`	$5.30	USD	Annual
Diluted earnings per share (in dollars per share)	`EarningsPerShareDiluted`	$5.28	USD	Annual
Diluted earnings per share (in dollars per share)	`EarningsPerShareDiluted`	$3.66	USD	Annual
Diluted earnings per share (in dollars per share)	`EarningsPerShareDiluted`	$0.01	USD	1 Quarter
Diluted earnings per share (in dollars per share)	`EarningsPerShareDiluted`	$2.72	USD	Annual
Weighted-average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.48B	shares	Annual
Weighted-average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.67B	shares	Annual
Weighted-average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.54B	shares	Annual
Weighted-average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.67B	shares	Annual
Weighted-average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.55B	shares	Annual
Weighted-average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.48B	shares	Annual

Cash Flow Statement 132 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`ProfitLoss`	$5.69B	USD	Annual
Net earnings	`ProfitLoss`	$7.88B	USD	Annual
Net earnings	`ProfitLoss`	$4.62B	USD	Annual
Depreciation	`Depreciation`	$666.00M	USD	Annual
Depreciation	`Depreciation`	$471.00M	USD	Annual
Depreciation	`Depreciation`	$464.00M	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$5.80B	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$1.55B	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$1.29B	USD	Annual
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-1.52B	USD	Annual
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-2.33B	USD	Annual
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$122.00M	USD	Annual
Change in fair value of contingent consideration liabilities	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$5.75B	USD	Annual
Change in fair value of contingent consideration liabilities	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$4.70B	USD	1 Quarter
Change in fair value of contingent consideration liabilities	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$49.00M	USD	Annual
Change in fair value of contingent consideration liabilities	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$3.09B	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$753.00M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$430.00M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$421.00M	USD	Annual
Upfront costs and milestones related to collaborations	`UpfrontCostsRelatedToCollaborations`	$490.00M	USD	Annual
Upfront costs and milestones related to collaborations	`UpfrontCostsRelatedToCollaborations`	$1.38B	USD	Annual
Upfront costs and milestones related to collaborations	`UpfrontCostsRelatedToCollaborations`	$1.06B	USD	Annual
Gain on divestitures	`GainLossOnSaleOfOtherAssets`	-	USD	Annual
Gain on divestitures	`GainLossOnSaleOfOtherAssets`	$330.00M	USD	Annual
Gain on divestitures	`GainLossOnSaleOfOtherAssets`	-	USD	Annual
Intangible asset impairment	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$5.07B	USD	Annual
Intangible asset impairment	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	Annual
Intangible asset impairment	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$1.03B	USD	Annual
Impacts related to U.S. tax reform	`ImpactsRelatedToU.S.TaxReform`	$424.00M	USD	Annual
Impacts related to U.S. tax reform	`ImpactsRelatedToU.S.TaxReform`	-	USD	Annual
Impacts related to U.S. tax reform	`ImpactsRelatedToU.S.TaxReform`	-	USD	Annual
Other, net	`OtherNoncashIncomeExpense`	$-43.00M	USD	Annual
Other, net	`OtherNoncashIncomeExpense`	$-76.00M	USD	Annual
Other, net	`OtherNoncashIncomeExpense`	$-832.00M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$74.00M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$591.00M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$929.00M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$231.00M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$40.00M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$226.00M	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$200.00M	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-134.00M	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$225.00M	USD	Annual
Accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$1.51B	USD	Annual
Accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$734.00M	USD	Annual
Accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$97.00M	USD	Annual
Income tax assets and liabilities, net	`IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable`	$-573.00M	USD	Annual
Income tax assets and liabilities, net	`IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable`	$674.00M	USD	Annual
Income tax assets and liabilities, net	`IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable`	$-1.02B	USD	Annual
Cash flows from operating activities	`NetCashProvidedByUsedInOperatingActivities`	$17.59B	USD	Annual
Cash flows from operating activities	`NetCashProvidedByUsedInOperatingActivities`	$13.43B	USD	Annual
Cash flows from operating activities	`NetCashProvidedByUsedInOperatingActivities`	$13.32B	USD	Annual
Acquisition of businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	Annual
Acquisition of businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$38.26B	USD	Annual
Acquisition of businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	Annual
Other acquisitions and investments	`PaymentsToAcquireOtherInvestments`	$1.35B	USD	Annual
Other acquisitions and investments	`PaymentsToAcquireOtherInvestments`	$1.14B	USD	Annual
Other acquisitions and investments	`PaymentsToAcquireOtherInvestments`	$736.00M	USD	Annual
Acquisitions of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$552.00M	USD	Annual
Acquisitions of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$798.00M	USD	Annual
Acquisitions of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$638.00M	USD	Annual
Purchases of investment securities	`PaymentsToAcquireMarketableSecurities`	$61.00M	USD	Annual
Purchases of investment securities	`PaymentsToAcquireMarketableSecurities`	$1.79B	USD	Annual
Purchases of investment securities	`PaymentsToAcquireMarketableSecurities`	$583.00M	USD	Annual
Sales and maturities of investment securities	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$2.70B	USD	Annual
Sales and maturities of investment securities	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$2.16B	USD	Annual
Sales and maturities of investment securities	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$1.52B	USD	Annual
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	-	USD	Annual
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-1.39B	USD	Annual
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-167.00M	USD	Annual
Cash flows from investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.01B	USD	Annual
Cash flows from investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-37.56B	USD	Annual
Cash flows from investing activities	`NetCashProvidedByUsedInInvestingActivities`	$596.00M	USD	Annual
Net change in commercial paper borrowings	`ProceedsFromRepaymentsOfCommercialPaper`	$299.00M	USD	Annual
Net change in commercial paper borrowings	`ProceedsFromRepaymentsOfCommercialPaper`	$-699.00M	USD	Annual
Net change in commercial paper borrowings	`ProceedsFromRepaymentsOfCommercialPaper`	-	USD	Annual
Proceeds from issuance of other short-term borrowings	`ProceedsFromOtherShortTermDebt`	$3.00B	USD	Annual
Proceeds from issuance of other short-term borrowings	`ProceedsFromOtherShortTermDebt`	-	USD	Annual
Proceeds from issuance of other short-term borrowings	`ProceedsFromOtherShortTermDebt`	-	USD	Annual
Repayments of other short-term borrowings	`RepaymentsOfOtherShortTermDebt`	$3.00B	USD	Annual
Repayments of other short-term borrowings	`RepaymentsOfOtherShortTermDebt`	-	USD	Annual
Repayments of other short-term borrowings	`RepaymentsOfOtherShortTermDebt`	-	USD	Annual
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$3.00B	USD	Annual
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$5.96B	USD	Annual
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$31.48B	USD	Annual
Repayments of long-term debt and finance lease obligations	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$5.68B	USD	Annual
Repayments of long-term debt and finance lease obligations	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$6.04B	USD	Annual
Repayments of long-term debt and finance lease obligations	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$1.54B	USD	Annual
Debt issuance costs	`PaymentOfFinancingAndStockIssuanceCosts`	$20.00M	USD	Annual
Debt issuance costs	`PaymentOfFinancingAndStockIssuanceCosts`	$424.00M	USD	Annual
Debt issuance costs	`PaymentOfFinancingAndStockIssuanceCosts`	$40.00M	USD	Annual
Dividends paid	`PaymentsOfDividends`	$5.58B	USD	Annual
Dividends paid	`PaymentsOfDividends`	$6.37B	USD	Annual
Dividends paid	`PaymentsOfDividends`	$7.72B	USD	Annual
Purchases of treasury stock	`PaymentsForRepurchaseOfCommonStock`	$12.01B	USD	Annual
Purchases of treasury stock	`PaymentsForRepurchaseOfCommonStock`	$629.00M	USD	Annual
Purchases of treasury stock	`PaymentsForRepurchaseOfCommonStock`	$978.00M	USD	Annual
Proceeds from the exercise of stock options	`ProceedsFromStockOptionsExercised`	$8.00M	USD	Annual
Proceeds from the exercise of stock options	`ProceedsFromStockOptionsExercised`	$73.00M	USD	Annual
Proceeds from the exercise of stock options	`ProceedsFromStockOptionsExercised`	$209.00M	USD	Annual
Payments of contingent consideration liabilities	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$78.00M	USD	Annual
Payments of contingent consideration liabilities	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$321.00M	USD	Annual
Payments of contingent consideration liabilities	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$163.00M	USD	Annual
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$8.00M	USD	Annual
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$14.00M	USD	Annual
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$35.00M	USD	Annual
Cash flows from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-11.50B	USD	Annual
Cash flows from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$18.71B	USD	Annual
Cash flows from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-14.40B	USD	Annual
Effect of exchange rate changes on cash and equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-39.00M	USD	Annual
Effect of exchange rate changes on cash and equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$7.00M	USD	Annual
Effect of exchange rate changes on cash and equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-5.00M	USD	Annual
Net change in cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-2.01B	USD	Annual
Net change in cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$32.63B	USD	Annual
Net change in cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-31.48B	USD	Annual
Cash and equivalents, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.45B	USD	Point-in-time
Cash and equivalents, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.29B	USD	Point-in-time
Cash and equivalents, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.30B	USD	Point-in-time
Cash and equivalents, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$39.92B	USD	Point-in-time
Cash and equivalents, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.45B	USD	Point-in-time
Cash and equivalents, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.29B	USD	Point-in-time
Cash and equivalents, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.30B	USD	Point-in-time
Cash and equivalents, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$39.92B	USD	Point-in-time
Interest paid, net of portion capitalized	`InterestPaidNet`	$1.79B	USD	Annual
Interest paid, net of portion capitalized	`InterestPaidNet`	$1.22B	USD	Annual
Interest paid, net of portion capitalized	`InterestPaidNet`	$2.62B	USD	Annual
Income taxes paid	`IncomeTaxesPaid`	$1.45B	USD	Annual
Income taxes paid	`IncomeTaxesPaid`	$1.67B	USD	Annual
Income taxes received	`ProceedsFromIncomeTaxRefunds`	$35.00M	USD	Annual
Issuance of common shares associated with acquisitions of businesses	`StockIssued1`	-	USD	Annual
Issuance of common shares associated with acquisitions of businesses	`StockIssued1`	$23.98B	USD	Annual
Issuance of common shares associated with acquisitions of businesses	`StockIssued1`	-	USD	Annual

Stockholders Equity 26 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.10B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-8.17B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.10B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-8.45B	USD	Point-in-time
Net earnings attributable to AbbVie Inc.	`NetIncomeLoss`	$5.69B	USD	Annual
Net earnings attributable to AbbVie Inc.	`NetIncomeLoss`	$4.62B	USD	Annual
Net earnings attributable to AbbVie Inc.	`NetIncomeLoss`	$7.88B	USD	Annual
Net earnings attributable to AbbVie Inc.	`NetIncomeLoss`	$36.00M	USD	1 Quarter
Other comprehensive income, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$479.00M	USD	Annual
Other comprehensive income, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-1.12B	USD	Annual
Other comprehensive income, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$247.00M	USD	Annual
Dividends declared	`DividendsCommonStockCash`	$6.53B	USD	Annual
Dividends declared	`DividendsCommonStockCash`	$6.04B	USD	Annual
Dividends declared	`DividendsCommonStockCash`	$8.28B	USD	Annual
Purchases of treasury stock	`TreasuryStockValueAcquiredCostMethod`	$428.00M	USD	Annual
Purchases of treasury stock	`TreasuryStockValueAcquiredCostMethod`	$12.21B	USD	Annual
Purchases of treasury stock	`TreasuryStockValueAcquiredCostMethod`	$978.00M	USD	Annual
Common shares and equity awards issued for acquisition of Allergan plc	`StockIssuedDuringPeriodValueAcquisitions`	$24.41B	USD	Annual
Stock-based compensation plans and other	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.00B	USD	Annual
Stock-based compensation plans and other	`StockIssuedDuringPeriodValueShareBasedCompensation`	$516.00M	USD	Annual
Stock-based compensation plans and other	`StockIssuedDuringPeriodValueShareBasedCompensation`	$469.00M	USD	Annual
Change in noncontrolling interest	`MinorityInterestPeriodIncreaseDecrease`	$21.00M	USD	Annual
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.10B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-8.17B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.10B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-8.45B	USD	Point-in-time

Comprehensive Income 45 line items

Line Item	Tag	Value	Unit	Period
Foreign currency translation adjustments, tax expense (benefit)	`OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax`	$-4.00M	USD	Annual
Foreign currency translation adjustments, tax expense (benefit)	`OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax`	$28.00M	USD	Annual
Net earnings	`ProfitLoss`	$5.69B	USD	Annual
Net earnings	`ProfitLoss`	$7.88B	USD	Annual
Foreign currency translation adjustments, tax expense (benefit)	`OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax`	$-18.00M	USD	Annual
Net earnings	`ProfitLoss`	$4.62B	USD	Annual
Net investment hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossNetInvestmentHedgeTax`	$22.00M	USD	Annual
Foreign currency translation adjustments, net of tax expense (benefit) of $28 in 2020, $(4) in 2019 and $(18) in 2018	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$1.51B	USD	Annual
Foreign currency translation adjustments, net of tax expense (benefit) of $28 in 2020, $(4) in 2019 and $(18) in 2018	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-98.00M	USD	Annual
Foreign currency translation adjustments, net of tax expense (benefit) of $28 in 2020, $(4) in 2019 and $(18) in 2018	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-391.00M	USD	Annual
Net investment hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossNetInvestmentHedgeTax`	$40.00M	USD	Annual
Net investment hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossNetInvestmentHedgeTax`	$-221.00M	USD	Annual
Net investment hedging activities, net of tax expense (benefit) of $(221) in 2020, $22 in 2019 and $40 in 2018	`OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTax`	$-799.00M	USD	Annual
Pension and post-employment benefits, tax expense (benefit)	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax`	$-35.00M	USD	Annual
Pension and post-employment benefits, tax expense (benefit)	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax`	$323.00M	USD	Annual
Pension and post-employment benefits, tax expense (benefit)	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax`	$47.00M	USD	Annual
Net investment hedging activities, net of tax expense (benefit) of $(221) in 2020, $22 in 2019 and $40 in 2018	`OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTax`	$74.00M	USD	Annual
Net investment hedging activities, net of tax expense (benefit) of $(221) in 2020, $22 in 2019 and $40 in 2018	`OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTax`	$138.00M	USD	Annual
Marketable securities activities, tax expense (benefit)	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	-	USD	Annual
Pension and post-employment benefits, net of tax expense (benefit) of $(47) in 2020, $(323) in 2019 and $35 in 2018	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-197.00M	USD	Annual
Marketable securities activities, tax expense (benefit)	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	-	USD	Annual
Pension and post-employment benefits, net of tax expense (benefit) of $(47) in 2020, $(323) in 2019 and $35 in 2018	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$1.24B	USD	Annual
Pension and post-employment benefits, net of tax expense (benefit) of $(47) in 2020, $(323) in 2019 and $35 in 2018	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$102.00M	USD	Annual
Marketable securities activities, tax expense (benefit)	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	-	USD	Annual
Marketable security activities, net of tax expense (benefit) of $ in 2020, $ in 2019 and $ in 2018	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$10.00M	USD	Annual
Marketable security activities, net of tax expense (benefit) of $ in 2020, $ in 2019 and $ in 2018	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-10.00M	USD	Annual
Cash flow hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax`	$-23.00M	USD	Annual
Marketable security activities, net of tax expense (benefit) of $ in 2020, $ in 2019 and $ in 2018	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	-	USD	Annual
Cash flow hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax`	$23.00M	USD	Annual
Cash flow hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax`	$70.00M	USD	Annual
Cash flow hedging activities, net of tax expense (benefit) of $(23) in 2020, $70 in 2019 and $23 in 2018	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-131.00M	USD	Annual
Cash flow hedging activities, net of tax expense (benefit) of $(23) in 2020, $70 in 2019 and $23 in 2018	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$141.00M	USD	Annual
Cash flow hedging activities, net of tax expense (benefit) of $(23) in 2020, $70 in 2019 and $23 in 2018	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$313.00M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$479.00M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-1.12B	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$247.00M	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$5.10B	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$5.93B	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$6.77B	USD	Annual
Comprehensive income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	-	USD	Annual
Comprehensive income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	-	USD	Annual
Comprehensive income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$6.00M	USD	Annual
Comprehensive income attributable to AbbVie Inc.	`ComprehensiveIncomeNetOfTax`	$5.09B	USD	Annual
Comprehensive income attributable to AbbVie Inc.	`ComprehensiveIncomeNetOfTax`	$6.77B	USD	Annual
Comprehensive income attributable to AbbVie Inc.	`ComprehensiveIncomeNetOfTax`	$5.93B	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.